Business
Inpixon Announces Merger with XTI Aircraft, Rebrands as XTI Aerospace
Inpixon, a leader in real-time location systems (RTLS) technology, has announced a significant milestone in its corporate journey: the anticipated closing of its merger with...
L.S. Starrett Co. Announces Go-Private Merger Agreement with MiddleGround Capital, Sparking Stock Surge*
In a strategic move set to redefine its trajectory, L.S. Starrett Co. announced today its definitive merger agreement with MiddleGround Capital in a transformative go-private...
Solidion Technology Surges Over 250% on NASDAQ Top Ten Gainers List
Solidion Technology Inc has captured the spotlight on Wall Street, emerging as one of the top ten gainers on the NASDAQ with a staggering 253.46%...
Market Update: US Stocks Slip, Bitcoin Surges Ahead
US stocks opened the week with a cautious slide on Monday, following a week of losses, while Bitcoin (BTC-USD) surged to new heights, adding to...
Market Closes Trading Week with a Somber Note as Tech Stocks Slump
In a tumultuous end to the trading week, the stock market closed with a somber note on Friday, as investors opted for caution following the...
The Joint Corp Surges After Q4 Financial Results
The Joint Corp released its financial results for Q4 and full year 2023 through an 8-K filing, shedding light on its revenue growth and operational...
Psyence Biomedical Stock Skyrockets on Phase IIb Study Approval
Psyence Biomedical experiences a dramatic surge in its stock value as its subsidiary, Psyence Australia, receives approval from the Human Research Ethics Committee (HREC) to...
AerSale Corp Release Financial Q4 Results, Stock Dips
AerSale Corp Q4 Financial Results Disclosure AerSale Corp, a global leader in aviation aftermarket products and services, has revealed its financial results for the fourth...
Scorpius Holdings Prices Public Offering Amid Volatile Trading
Scorpius Holdings Public Offering and Pricing Details Scorpius Holdings, a prominent contract development and manufacturing organization (CDMO), has announced the pricing of its underwritten public...
Amylyx Pharmaceuticals Plunges as ALS Drug Trial Fails, Raising Questions on FDA Approval
Amylyx Pharmaceuticals experiences a significant drop in its stock value after its drug for amyotrophic lateral sclerosis (ALS) failed to demonstrate benefits for patients in...
